Valuation : Assure Holdings Corp.

Market Cap 144K 124K 117K 106K 199K 13.56M 200K 1.38M 536K 6.93M 539K 527K 22.78M P/E 2022
-0.13x
P/E 2023 -0.04x
Enterprise Value 14.83M 12.79M 12.05M 10.98M 20.52M 1.4B 20.67M 143M 55.36M 716M 55.67M 54.45M 2.35B EV / Sales 2022
1.68x
EV / Sales 2023 -4x
Free-Float
100%
Yield 2022 *
-
Yield 2023 -
Current year 0
Extreme 0.0001
4.2
1 year 0
Extreme 0.0001
4.2
3 years 0
Extreme 1.0E-6
17.64
5 years 0
Extreme 1.0E-6
2,934
10 years 0
Extreme 1.0E-6
6,299.99
Manager TitleAgeSince
Chief Executive Officer 67 2018-05-14
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 2021-06-16
Director TitleAgeSince
Chairman 67 2018-05-14
Director/Board Member 58 2018-12-18
Director/Board Member 76 2019-09-18
Date Insider Type Main position Quantity % Market Cap. Importance
4/11/23 Buy

Director

2,609 0.2369%
4/11/23 Sell 2,500 0.2270%
4/11/23 Buy

Director

500 0.0454%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-98.96%-99.99% 1.84K
-0.38%+4.66%+32.92%+48.06% 125B
-2.79%-6.23%-0.47%+43.18% 89.54B
-2.48%+0.02%-1.83%+55.76% 29.24B
+1.94%-1.52%+32.57%+84.49% 26.07B
-1.79%-4.11%-5.49%-5.02% 21.91B
-2.75%-4.91%+40.25%+228.50% 21.41B
+4.06%+5.18%-4.67%+27.59% 15.11B
-0.46%-2.48%-10.63%-11.39% 12.15B
+1.85%+0.89%+30.22%+74.18% 11.23B
Average -0.50%-1.02%+1.39%+44.54% 35.15B
Weighted average by Cap. -1.02%+0.20%+16.34%+55.74%

Financials

2022 2023
Net sales 10.98M 9.47M 8.92M 8.13M 15.19M 1.04B 15.3M 106M 40.98M 530M 41.22M 40.31M 1.74B -4.1M -3.54M -3.33M -3.04M -5.68M -388M -5.72M -39.48M -15.32M -198M -15.41M -15.07M -651M
Net income -30.11M -25.98M -24.47M -22.3M -41.68M -2.84B -41.99M -290M -112M -1.45B -113M -111M -4.78B -26.08M -22.5M -21.19M -19.31M -36.09M -2.46B -36.36M -251M -97.38M -1.26B -97.93M -95.78M -4.14B
Net Debt 13.45M 11.6M 10.93M 9.96M 18.61M 1.27B 18.75M 129M 50.21M 649M 50.5M 49.39M 2.13B 14.68M 12.67M 11.93M 10.87M 20.32M 1.39B 20.47M 141M 54.82M 709M 55.13M 53.93M 2.33B
Logo Assure Holdings Corp.
Assure Holdings Corp. is a provider of Intraoperative neuromonitoring (IONM). The Company delivers a suite of clinical and operational services to support surgeons and medical facilities during invasive procedures. Its IONM tool is used for various surgical verticals, such as neurosurgery, spine, cardiovascular, orthopedic, ear, nose, and throat (ENT), and other surgical procedures. Its in-house interoperative neurophysiologists (INP) provide the technical component IONM services from the operating room throughout the procedure, while telehealth-oriented supervising practitioners provide a level of redundancy and risk mitigation in support of the onsite INPs and the surgical team. It offers IONM services, including scheduling the INP and supervising practitioner, real-time monitoring, patient advocacy and subsequent billing for services provided. During each procedure, it provides two types of services, the Technical Component and Professional Component of IONM.
Employees
95
Date Price Change Volume
26-08-26 US$0.000000 - 17
  1. Stock Market
  2. Stocks
  3. IONM Stock